Venture Valuation AG: The Genedata Assignment

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Case

Reference no. IMD-1-0241

Subject category: Finance, Accounting and Control

Authors: Benoit Leleux (International Institute for Management Development (IMD)); Victoria Kemanian (International Institute for Management Development (IMD)); Atul Pahwa (International Institute for Management Development (IMD)); Katrin Siebenburger (International Institute for Management Development (IMD))

Published by: International Institute for Management Development (IMD)

Originally published in: 2005

Version: 24.10.2016

Revision date: 5-Jan-2017

Length: 17 pages

Data source: Field research

Topics: Venture capital; Entrepreneurship; Valuation; Pharmaceutical; Start-up; Company; Finance

Share a link: https://casecent.re/p/69325

| No reviews for this item

View our pricing guide or login to see prices.

Abstract

This is part of a case series. Venture Valuation conducts an independent valuation of Genedata, a Swiss start-up company in order to help Novartis Venture Fund analyse and structure the next financing round. Venture Valuation has to, given a very tight deadline, customise the evaluation process to using quantitative and qualitative data to best meet its customers needs. The case outlines the task ahead of Venture Valuation and requires students to make assessments and calculations and finally come up with a valuation for the start-up, Genedata.

Location:

Switzerland

Size:

Small, start-up

Other setting(s):

July 1999